New Advances on Disease Biomarkers and Molecular Targets in Biomedicine (Record no. 96201)

000 -LEADER
fixed length control field 04225nam a22004815i 4500
001 - CONTROL NUMBER
control field 978-1-62703-456-2
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20140220082834.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 130622s2013 xxu| s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781627034562
-- 978-1-62703-456-2
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/978-1-62703-456-2
Source of number or code doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number QH573-671
072 #7 - SUBJECT CATEGORY CODE
Subject category code PSF
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code SCI049000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 571.6
Edition number 23
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Lee, Nikki P.
Relator term editor.
245 10 - TITLE STATEMENT
Title New Advances on Disease Biomarkers and Molecular Targets in Biomedicine
Medium [electronic resource] /
Statement of responsibility, etc edited by Nikki P. Lee, C.Y. Cheng, John M. Luk.
264 #1 -
-- Totowa, NJ :
-- Humana Press :
-- Imprint: Humana Press,
-- 2013.
300 ## - PHYSICAL DESCRIPTION
Extent XII, 275 p. 34 illus., 29 illus. in color.
Other physical details online resource.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
347 ## -
-- text file
-- PDF
-- rda
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Non-receptor Protein Kinases c-Src, c-Yes and FAK are Biomarkers for Male Contraceptive Research -- Ankyrin Repeat and Suppressor of Cytokine Signaling Box (ASB) Family Members for Cancer Diagnosis, Prognosis, and Treatment -- MicroRNA as Cancer Biomarkers and Targets -- Oncofetal Molecules as Biomarkers and Drug Targets for Hepatic Cancer -- Ion channels as novel pancreatic cancer biomarkers and targets -- Circulating Biomarkers for Sophageal Squamous Cell Carcinoma -- Using Genomic Biomarkers to Predict Patient Prognosis and Treatment Response in Gastric Cancer -- CARF Regulates Cellular Senescence and Apoptosis by p53 Dependant and Independent Pathways -- Targeting Cancer Metabolisms -- Modulation of Autophagy as a Novel Cancer Therapeutic Strategy -- Functional proteomics screening for novel anti-viral drug targets -- Identification of Tumor Antigens as Targets for Novel Anti-tumor Therapies -- Mesoporous Silica Nanoparticles for Cancer Therapy -- Chemoresistance in Glioma.
520 ## - SUMMARY, ETC.
Summary, etc Rising occurrences of various diseases and epidemics have pressurized the already-burdened health system across the globe, and this imposes an unprecedented challenge on our current research in identifying disease-specific biomarkers and molecular targets, in particular for cancers, neurological disorders and unexplained infertility. Despite decades of efforts in deciphering the fundamental biology underlying various diseases at discrete levels using an array of advanced technologies, attempts to identify reliable and disease-indicating markers for detection and biomolecules or cellular structures for targeting are still in vain. This monograph describes and discusses the updated findings in this field with a specific aim to compile prior and recent literature and from there to acquire some insights to facilitate future research to expand our options of understanding, detecting and treating diseases. Among the many possible areas of biomedical research, this content comprises two themes: disease biomarkers and molecular targets. We also cover topics that are more advanced in development to emerging scientific discoveries. In particular, we have included in this monograph concepts on the renovated use of oncofetal molecules in cancer prediction and treatment, the evolving development in cancer biology at the cellular and molecular levels and the recent involvement on new classes of molecules in diseases. We hope that this book can renew established concepts in the field, and at the same time lead to important insights for research and development of drugs, diagnostics, and interventions for managing diseases of unmet medical needs.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Life sciences.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Oncology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Toxicology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cytology.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Life Sciences.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cell Biology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer Research.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacology/Toxicology.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cheng, C.Y.
Relator term editor.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Luk, John M.
Relator term editor.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed edition:
International Standard Book Number 9781627034555
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-1-62703-456-2
912 ## -
-- ZDB-2-SBL

No items available.

2017 | The Technical University of Kenya Library | +254(020) 2219929, 3341639, 3343672 | library@tukenya.ac.ke | Haile Selassie Avenue